Serrano Peter, Yao Yudong, Sacktor Todd Charlton
Department of Physiology, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA.
J Neurosci. 2005 Feb 23;25(8):1979-84. doi: 10.1523/JNEUROSCI.5132-04.2005.
Protein kinase Mzeta (PKMzeta), an autonomously active atypical PKC isoform, is both necessary and sufficient for enhanced synaptic transmission during long-term potentiation (LTP) maintenance. LTP, however, evolves through several temporal phases, which may be mediated by distinct molecular mechanisms of potentiation. Here, we determined the specific phase of LTP maintained by PKMzeta. Using a selective, cell-permeable zeta-pseudosubstrate inhibitor at concentrations that block potentiation produced by postsynaptic perfusion of PKMzeta, we inhibited PKMzeta activity at various times after tetanization of Schaffer collateral/commissural-CA1 synapses. Inhibition of PKMzeta did not affect baseline AMPA receptor-mediated synaptic transmission or an early phase of LTP. In contrast, the inhibitor reversed established LTP when applied 1, 3, or 5 h after tetanic stimulation. Control nontetanized pathways within the hippocampal slices were unaffected. An inactive scrambled version of the peptide had no effect on LTP. Thus, persistent, increased phosphorylation by PKMzeta specifically maintains the late phase of LTP.
蛋白激酶Mζ(PKMzeta)是一种自主活性的非典型蛋白激酶C亚型,在长时程增强(LTP)维持过程中,对于增强突触传递而言,它既是必要的,也是充分的。然而,LTP是通过几个时间阶段逐步形成的,这可能由不同的增强分子机制介导。在此,我们确定了由PKMzeta维持的LTP的特定阶段。使用一种选择性的、可透过细胞的ζ-假底物抑制剂,其浓度能够阻断突触后灌注PKMzeta所产生的增强效应,我们在刺激海马体的谢弗侧支/联合-海马体CA1突触后的不同时间抑制PKMzeta的活性。抑制PKMzeta并不影响基线AMPA受体介导的突触传递或LTP的早期阶段。相反,在强直刺激后1、3或5小时应用该抑制剂时,它能逆转已建立的LTP。海马体切片内未受刺激的对照通路不受影响。该肽的无活性乱序版本对LTP没有影响。因此,PKMzeta持续增加的磷酸化作用专门维持LTP的晚期阶段。